miR-17-3p Exacerbates Oxidative Damage in Human Retinal Pigment Epithelial Cells

Bo Tian1,2, Daniel E Maidana1, Bernard Dib1

  • 1Retina Service, Angiogenesis Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, United States of America.

Plos One
|August 10, 2016
PubMed

Insights

MicroRNA-17-3p (miR-17-3p) worsens oxidative stress in eye cells, contributing to age-related macular degeneration. Inhibiting miR-17-3p may protect against this damage by regulating antioxidant enzymes.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Oxidative stress is implicated in age-related macular degeneration (AMD) pathogenesis.
  • MicroRNAs (miRNAs) regulate gene expression and are involved in cellular processes.
  • Elevated miR-17-3p levels are observed in AMD patient macular cells and under oxidative stress conditions.

Purpose of the Study:

  • To investigate the role of miR-17-3p in oxidative stress-induced cell death in retinal pigment epithelium (RPE) cells.
  • To determine if miR-17-3p influences the expression of key antioxidant enzymes.

Main Methods:

  • Utilized ARPE-19 cells, a human RPE cell line.
  • Employed miR-17-3p mimic and inhibitor transfections.
  • Assessed cell viability under oxidative stress conditions.
  • Quantified the expression levels of manganese superoxide dismutase (MnSOD) and thioredoxin reductase-2 (TrxR2).

Main Results:

  • miR-17-3p mimic transfection induced cell death and worsened oxidative stress lethality in ARPE-19 cells.
  • miR-17-3p inhibitor alleviated oxidative stress-induced cell death.
  • miR-17-3p mimic suppressed MnSOD and TrxR2 expression, while the inhibitor reversed this suppression.

Conclusions:

  • miR-17-3p exacerbates oxidative damage-induced cell death in human RPE cells.
  • miR-17-3p inhibition shows potential as a protective strategy against oxidative stress in AMD by modulating antioxidant enzyme expression.

Related Concept Videos